|
|
|
Volumn 25, Issue 4 SUPPL. 3, 1999, Pages 145-147
|
|
Past, present and future considerations on low molecular weight heparin differentiation: An epilogue
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DALTEPARIN;
ENOXAPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
REVIPARIN;
TINZAPARIN;
ANTICOAGULATION;
BIOEQUIVALENCE;
CONFERENCE PAPER;
DEEP VEIN THROMBOSIS;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
HEART MUSCLE ISCHEMIA;
HUMAN;
MOLECULAR WEIGHT;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
DRUG EVALUATION;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
|
|
EID: 0032728645
PISSN: 00946176
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (18)
|
|
References (21)
|